EuroEyes International Eye Clinic Limited (HKG:1846)
Hong Kong
· Delayed Price · Currency is HKD 2.850
-0.020 (-0.70%)
Apr 25, 2025, 3:06 PM HKT
HKG:1846 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Revenue | 715.68 | 714.29 | 610.29 | 632.93 | 473.82 | Upgrade
|
| Revenue Growth (YoY) | 0.19% | 17.04% | -3.58% | 33.58% | 10.27% | Upgrade
|
| Cost of Revenue | 429.09 | 378.77 | 339.45 | 320.39 | 259.72 | Upgrade
|
| Gross Profit | 286.59 | 335.52 | 270.84 | 312.55 | 214.1 | Upgrade
|
| Selling, General & Admin | 185.48 | 162.22 | 134.01 | 122.75 | 106.54 | Upgrade
|
| Other Operating Expenses | -3.94 | -4.86 | -3.95 | -1.87 | -2.67 | Upgrade
|
| Operating Expenses | 181.88 | 157.58 | 130.1 | 120.99 | 103.89 | Upgrade
|
| Operating Income | 104.72 | 177.94 | 140.75 | 191.56 | 110.21 | Upgrade
|
| Interest Expense | -10.04 | -9.7 | -7.12 | -7.49 | -7 | Upgrade
|
| Interest & Investment Income | 23.57 | 19.33 | 1.14 | 0.14 | 2.52 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.9 | -8.09 | 5.77 | 12.74 | -7.29 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.75 | -4.44 | -3.62 | -0.97 | -0.64 | Upgrade
|
| EBT Excluding Unusual Items | 115.4 | 175.04 | 136.92 | 195.97 | 97.8 | Upgrade
|
| Merger & Restructuring Charges | - | - | -3.29 | - | - | Upgrade
|
| Impairment of Goodwill | -11 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.08 | -0.38 | 0.21 | -0.29 | 0.18 | Upgrade
|
| Other Unusual Items | 23.15 | 15.96 | -4.85 | - | 0.67 | Upgrade
|
| Pretax Income | 126.47 | 190.61 | 128.98 | 195.67 | 98.65 | Upgrade
|
| Income Tax Expense | 42.11 | 57.36 | 45.46 | 63.29 | 34.58 | Upgrade
|
| Earnings From Continuing Operations | 84.36 | 133.25 | 83.52 | 132.38 | 64.07 | Upgrade
|
| Minority Interest in Earnings | -2.07 | -2.01 | 5.95 | 1.18 | 1.51 | Upgrade
|
| Net Income | 82.29 | 131.24 | 89.47 | 133.56 | 65.58 | Upgrade
|
| Net Income to Common | 82.29 | 131.24 | 89.47 | 133.56 | 65.58 | Upgrade
|
| Net Income Growth | -37.30% | 46.69% | -33.01% | 103.66% | - | Upgrade
|
| Shares Outstanding (Basic) | 330 | 332 | 332 | 328 | 329 | Upgrade
|
| Shares Outstanding (Diluted) | 330 | 332 | 332 | 329 | 376 | Upgrade
|
| Shares Change (YoY) | -0.60% | -0.01% | 0.95% | -12.38% | 46.44% | Upgrade
|
| EPS (Basic) | 0.25 | 0.40 | 0.27 | 0.41 | 0.20 | Upgrade
|
| EPS (Diluted) | 0.25 | 0.40 | 0.27 | 0.41 | 0.17 | Upgrade
|
| EPS Growth | -36.93% | 46.70% | -33.64% | 132.43% | - | Upgrade
|
| Free Cash Flow | - | 102.94 | 152.74 | 229.28 | 40.12 | Upgrade
|
| Free Cash Flow Per Share | - | 0.31 | 0.46 | 0.70 | 0.11 | Upgrade
|
| Dividend Per Share | 0.065 | 0.100 | 0.063 | 0.099 | 0.030 | Upgrade
|
| Dividend Growth | -35.40% | 59.59% | -36.91% | 232.40% | - | Upgrade
|
| Gross Margin | 40.04% | 46.97% | 44.38% | 49.38% | 45.19% | Upgrade
|
| Operating Margin | 14.63% | 24.91% | 23.06% | 30.26% | 23.26% | Upgrade
|
| Profit Margin | 11.50% | 18.37% | 14.66% | 21.10% | 13.84% | Upgrade
|
| Free Cash Flow Margin | - | 14.41% | 25.03% | 36.23% | 8.47% | Upgrade
|
| EBITDA | 141.89 | 215.12 | 174.54 | 220.08 | 135.07 | Upgrade
|
| EBITDA Margin | 19.83% | 30.12% | 28.60% | 34.77% | 28.51% | Upgrade
|
| D&A For EBITDA | 37.18 | 37.18 | 33.79 | 28.52 | 24.87 | Upgrade
|
| EBIT | 104.72 | 177.94 | 140.75 | 191.56 | 110.21 | Upgrade
|
| EBIT Margin | 14.63% | 24.91% | 23.06% | 30.26% | 23.26% | Upgrade
|
| Effective Tax Rate | 33.30% | 30.09% | 35.25% | 32.34% | 35.05% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.